http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103665159-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-44
filingDate 2013-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2016-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103665159-B
titleOfInvention The method of efficiently purifying quantum dot and IgG class monoclonal antibody conjugate
abstract The invention discloses the new method of a kind of applicable scale efficiently purifying water-soluble quantum dot and IgG class monoclonal antibody conjugate, belong to biological technical field. For current quantum dot antibody coupling matter purifying process complexity; the rate of recovery is low; the drawback that is difficult to accomplish scale production; the present invention is by adopting the residual carboxyl of Glucosamine sealing quantum dot and antibody coupling matter; reduce the surperficial zeta potential of coupled product; by adjusting pH to 4.5~5.0, further reduce the net charge content of coupled product in solution, realize common supercentrifugal process scale efficiently purifying quantum dot and antibody coupling matter. The present invention has simplified the experimental implementation flow process of quantum dot and antibody coupling matter, reduce the requirement to separation equipment, be applicable to purifying quantum dot IgG class monoclonal antibody conjugate in enormous quantities, yield is more than 85%, and the fluorescent characteristic of coupled product and biologically active have no significant change.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108918858-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108918858-A
priorityDate 2013-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101587071-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006033732-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49789073
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID5059
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26574
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68205
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123195
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411478303
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559383
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID140625506
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID5059
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451936144
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483452
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518980
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415810504
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457588632
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65577
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419517759
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID753
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22629
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33557
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413364670

Total number of triples: 40.